The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial
Titel:
The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial
Auteur:
Mooi, J.K. Wirapati, P. Asher, R. Lee, C.K. Savas, P. Price, T.J. Townsend, A. Hardingham, J. Buchanan, D. Williams, D. Tejpar, S. Mariadason, J.M. Tebbutt, N.C.